Clinical Trial Update: Dupilumab for Eosinophilic Esophagitis With Severe Strictures [Phase 4]

View source ↗

Summary

This document reports a Phase 4 clinical trial of dupilumab for eosinophilic esophagitis with severe strictures, currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Esophagitis

Drugs mentioned

• Dupilumab (dupilumab)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Eosinophilic Esophagitis, EoE | Phase 4 | Status: ENROLLING_BY_INVITATION